Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle - Business News: Latest Share Market , Economy & Finance News | Trendmergers

Breaking

Post Top Ad

Post Top Ad

Dr Reddy's Labs launches copy of BI drug; move may lead to legal battle

Under its brand Vicra, Dr. Reddy's is expected to sell the drug in India at less than a third of the price charged by Boehringer Ingelheim. According to sources the 10 mg variant of Dr. Reddy's brand may cost ₹15 per tablet against ₹51 of the innovator's brand.

from Industry-Economic Times
Read The Rest:economictimes...

Post Top Ad